Circumvention of Gefitinib Resistance by Repurposing Flunarizine via Histone Deacetylase Inhibition.

To, Kenneth K W; Chow, James C H; Cheung, Ka-Man; Cho, William C S

To, Kenneth K W; Chow, James C H; Cheung, Ka-Man; Cho, William C S.

Afiliação

To KKW; School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, SAR, China.
Chow JCH; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, SAR, China.
Cheung KM; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, SAR, China.
Cho WCS; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, SAR, China.

ACS Pharmacol Transl Sci ; 6(10): 1531-1543, 2023 Oct 13.

Article em En | MEDLINE | ID: mdl-37854628

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article